Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (491-500 of 535) with videos related to

Pageof 54
Sort By:
Nature Reviews. Rheumatology|February 14, 2025
An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Rheumatology (Oxford, England)|January 8, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohortEliane Roth, Cosimo Bruni, Liubov Petelytska, et al.
Arthritis and Rheumatism|September 10, 2011
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediatorsJ C A Broen, L Bossini-Castillo, L van Bon, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|October 11, 2024
EULAR recommendations for the treatment of systemic sclerosis: 2023 updateFrancesco Del Galdo, Alain Lescoat, Philip G Conaghan, et al.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Rheumatology (Oxford, England)|April 11, 2026
Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenonCarlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Carlos Rosa-Baez, et al.
Plos One|December 27, 2018
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibilityDavid González-Serna, Elio G Carmona, Norberto Ortego-Centeno, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
Rheumatology Advances in Practice|March 16, 2023
Management of systemic sclerosis: British Society for Rheumatology guideline scopeChristopher P Denton, Enrico De Lorenzis, Elen Roblin, et al.
Pageof 54

Showing results (491-500 of 535) with videos related to

Sort By:
Pageof 54
Nature Reviews. Rheumatology|February 14, 2025
An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Rheumatology (Oxford, England)|January 8, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohortEliane Roth, Cosimo Bruni, Liubov Petelytska, et al.
Arthritis and Rheumatism|September 10, 2011
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediatorsJ C A Broen, L Bossini-Castillo, L van Bon, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|October 11, 2024
EULAR recommendations for the treatment of systemic sclerosis: 2023 updateFrancesco Del Galdo, Alain Lescoat, Philip G Conaghan, et al.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Rheumatology (Oxford, England)|April 11, 2026
Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenonCarlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Carlos Rosa-Baez, et al.
Plos One|December 27, 2018
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibilityDavid González-Serna, Elio G Carmona, Norberto Ortego-Centeno, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
Rheumatology Advances in Practice|March 16, 2023
Management of systemic sclerosis: British Society for Rheumatology guideline scopeChristopher P Denton, Enrico De Lorenzis, Elen Roblin, et al.
Pageof 54